Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling
- PMID: 28192397
- PMCID: PMC5422710
- DOI: 10.1038/onc.2016.414
"V体育官网入口" Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling
Abstract
Epithelial-mesenchymal transition (EMT) has been recognized as a key element of cell migration and invasion in lung cancer; however, the underlying mechanisms are not fully elucidated. Recently, emerging evidence suggest that miRNAs have crucial roles in control of EMT and EMT-associated traits such as migration, invasion and chemoresistance. Here, we found that miR-218 expression levels were significantly downregulated in lung cancer tissues compared with adjacent non-cancerous tissues, and the levels of miR-218 were significantly associated with histological grades and lymph node metastasis. Overexpression of miR-218 inhibited cell migration and invasion as well as the EMT process. Of particular importance, miR-218 was involved in the metastatic process of lung cancer cells in vivo by suppressing local invasion and distant colonization. We identified Slug and ZEB2 as direct functional targets of miR-218. Inverse correlations were observed between miR-218 levels and Slug/ZEB2 levels in cancer tissue samples. In addition, overexpression of miR-218 in H1299 increased chemosensitivity of cells to cisplatin treatment through suppression of Slug and ZEB2 VSports手机版. These findings highlight an important role of miR-218 in the regulation of EMT-related traits and metastasis of lung cancer in part by modulation of Slug/ZEB2 signaling, and provide a potential therapeutic strategy by targeting miR-218 in NSCLC. .
V体育官网 - Conflict of interest statement
The authors declare no conflict of interest.
Figures








VSports - References
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11–30. - PubMed
-
- Heist RS, Engelman JA. SnapShot: non-small cell lung cancer. Cancer Cell 2012; 21: 448 e442. - PubMed
-
- Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008; 26: 3543–3551. - PubMed
-
- Wu YC, Tang SJ, Sun GH, Sun KH. CXCR7 mediates TGFbeta1-promoted EMT and tumor-initiating features in lung cancer. Oncogene 2015; 35: 2123–2132. - "V体育平台登录" PubMed
-
- Zhang J, Tian XJ, Zhang H, Teng Y, Li R, Bai F et al. TGF-beta-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops. Sci Signal 2014; 7: ra91. - "V体育2025版" PubMed
Publication types
- "VSports在线直播" Actions
MeSH terms
- "V体育官网" Actions
- Actions (VSports手机版)
- V体育官网 - Actions
- "V体育官网入口" Actions
- "VSports手机版" Actions
- "VSports最新版本" Actions
- VSports最新版本 - Actions
- Actions (VSports在线直播)
V体育官网 - Substances
- Actions (VSports手机版)
- Actions (V体育官网入口)
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials